{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:42:14Z","timestamp":1789746134026,"version":"4.0.1"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"<jats:sec id=\"ab-doi220058-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>An increasing number of people develop more than 1 primary melanoma, yet to date, no population-based prospective cohort studies have reported on risk factors for developing first vs second primary melanomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi220058-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the clinical characteristics of first and second melanomas and then to estimate the relative risks of developing 1 vs multiple melanomas associated with demographic, phenotypic, sun exposure, and genetic factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi220058-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This population-based prospective cohort study included men and women aged 40 to 69 years recruited in 2011 and followed up until December 2018 in Queensland, Australia. Data analysis was performed from February to July 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi220058-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Self-reported information about demographic, phenotypic, and sun exposure measures captured using a survey completed at baseline, and polygenic risk score for melanoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi220058-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Incident first or second primary melanoma diagnosis, and histologic and clinical characteristics thereof. The Wei-Lin-Weissfeld model for recurrent events was used to estimate the association of each factor with the risks of first and second primary melanoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi220058-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 38\u202f845 patients (mean [SD] age at baseline, 56.1 [8.2] years; 17\u202f775 men and 21\u202f070 women) were included in the study. During a median follow-up period of 7.4 years, 1212 (3.1%) participants had a single primary melanoma diagnosis, and 245 (0.6%) had a second primary melanoma diagnosis. Second melanomas were more likely than first melanomas to be in situ; for invasive tumors, second melanomas were more likely to be thin (ie, \u22641 mm) than first melanomas. Having many moles at age 21 years (self-reported using visual scoring tool) was more strongly associated with second (hazard ratio [HR], 6.36; 95% CI, 3.77-10.75) than first primary melanoma (HR, 3.46; 95% CI, 2.72-4.40) (\n                      <jats:italic>P<\/jats:italic>\n                      value for difference between the HRs\u2009=\u2009.01). A high genetic predisposition (ie, polygenic risk score in tertile 3) was also more strongly associated with second (HR, 3.28; 95% CI, 2.06-5.23) than first melanoma (HR, 2.06; 95% CI, 1.71-2.49;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.03). Second melanomas were more strongly associated with a history of multiple skin cancer excisions (HR, 2.63; 95% CI, 1.80-3.83) than first melanomas (HR, 1.86; 95% CI, 1.61-2.16;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.05). For all other phenotypic characteristics and sun exposure measures, similarly elevated associations with first vs second melanomas were observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi220058-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Findings of this cohort study suggest that within the general population, the presence of many nevi and having a high genetic predisposition to melanoma were associated with the highest risks of developing second primary melanomas.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamadermatol.2022.4975","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T11:34:08Z","timestamp":1669203248000},"page":"37","source":"Crossref","is-referenced-by-count":15,"title":["Risk Factors Associated With First and Second Primary Melanomas in a High-Incidence Population"],"prefix":"10.1001","volume":"159","author":[{"given":"Catherine M.","family":"Olsen","sequence":"first","affiliation":[{"name":"Departments of Population Health and Computational Biology, QIMR Berghofer Medical Research Institute, Queensland, Australia"},{"name":"Faculty of Medicine, University of Queensland, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala","family":"Pandeya","sequence":"additional","affiliation":[{"name":"Departments of Population Health and Computational Biology, QIMR Berghofer Medical Research Institute, Queensland, Australia"},{"name":"Faculty of Medicine, University of Queensland, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claude","family":"Dusingize","sequence":"additional","affiliation":[{"name":"Departments of Population Health and Computational Biology, QIMR Berghofer Medical Research Institute, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Neale","sequence":"additional","affiliation":[{"name":"Departments of Population Health and Computational Biology, QIMR Berghofer Medical Research Institute, Queensland, Australia"},{"name":"Faculty of Medicine, University of Queensland, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"MacGregor","sequence":"additional","affiliation":[{"name":"Departments of Population Health and Computational Biology, QIMR Berghofer Medical Research Institute, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.","family":"Law","sequence":"additional","affiliation":[{"name":"Departments of Population Health and Computational Biology, QIMR Berghofer Medical Research Institute, Queensland, Australia"},{"name":"Faculty of Health, Queensland University of Technology, Queensland, Australia"},{"name":"School of Biomedical Sciences, University of Queensland, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Whiteman","sequence":"additional","affiliation":[{"name":"Departments of Population Health and Computational Biology, QIMR Berghofer Medical Research Institute, Queensland, Australia"},{"name":"Faculty of Medicine, University of Queensland, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"QSkin Study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas K.","family":"Hayward","sequence":"additional","affiliation":[{"name":"for the QSkin Study"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiarash","family":"Khosrotehrani","sequence":"additional","affiliation":[{"name":"for the QSkin Study"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa G.","family":"Gordon","sequence":"additional","affiliation":[{"name":"for the QSkin Study"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"11","key":"doi220058r1","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1111\/jdv.13144","article-title":"Survival outcomes in patients with multiple primary melanomas.","volume":"29","author":"Rowe","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"13","key":"doi220058r2","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1001\/jama.294.13.1647","article-title":"Clinicopathological features of and risk factors for multiple primary melanomas.","volume":"294","author":"Ferrone","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"doi220058r3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1001\/archderm.142.4.433","article-title":"Multiple primary melanoma: two-year results from a population-based study.","volume":"142","author":"Titus-Ernstoff","year":"2006","journal-title":"Arch Dermatol"},{"issue":"17","key":"doi220058r4","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1002\/cncr.27407","article-title":"Single versus multiple primary melanomas: old questions and new answers.","volume":"118","author":"Hwa","year":"2012","journal-title":"Cancer"},{"issue":"6","key":"doi220058r5","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.jid.2018.12.006","article-title":"Trends in melanoma incidence rates in eight susceptible populations through 2015.","volume":"139","author":"Olsen","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"6","key":"doi220058r6","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jid.2016.01.035","article-title":"The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031.","volume":"136","author":"Whiteman","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"5","key":"doi220058r7","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2105\/AJPH.2020.305567","article-title":"New systematic therapies and trends in cutaneous melanoma deaths among US Whites, 1986-2016.","volume":"110","author":"Berk-Krauss","year":"2020","journal-title":"Am J Public Health"},{"issue":"6","key":"doi220058r8","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/bjd.v183.6","article-title":"Trends in malignant melanoma mortality in 31 countries from 1985 to 2015.","volume":"183","author":"Yang","year":"2020","journal-title":"Br J Dermatol"},{"issue":"4","key":"doi220058r9","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jaad.2015.06.059","article-title":"Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011.","volume":"73","author":"Moore","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi220058r10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/jnci\/djaa088","article-title":"Multiple primary melanoma incidence trends over five decades: a nationwide population-based study.","volume":"113","author":"Helgadottir","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"doi220058r11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/ije\/dyl044","article-title":"A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma.","volume":"35","author":"Begg","year":"2006","journal-title":"Int J Epidemiol"},{"issue":"2","key":"doi220058r12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/jamadermatol.2018.4645","article-title":"Risk factors of subsequent primary melanomas in Austria.","volume":"155","author":"M\u00fcller","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"9","key":"doi220058r13","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/jamadermatol.2019.1134","article-title":"Comparison of survival between patients with single vs multiple primary cutaneous melanomas.","volume":"155","author":"El Sharouni","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"3","key":"doi220058r14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10552-006-0091-x","article-title":"Ambient UV, personal sun exposure and risk of multiple primary melanomas.","volume":"18","author":"Kricker","year":"2007","journal-title":"Cancer Causes Control"},{"issue":"5","key":"doi220058r15","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/bjd.v182.5","article-title":"A risk prediction model for the development of subsequent primary melanoma in a population-based cohort.","volume":"182","author":"Cust","year":"2020","journal-title":"Br J Dermatol"},{"issue":"6","key":"doi220058r16","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1158\/1055-9965.EPI-14-1426","article-title":"Inherited genetic variants associated with occurrence of multiple primary melanoma.","volume":"24","author":"Gibbs","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"doi220058r17","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/ije\/dys107","article-title":"Cohort profile: the QSkin Sun and Health Study.","volume":"41","author":"Olsen","year":"2012","journal-title":"Int J Epidemiol"},{"issue":"12","key":"doi220058r18","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jclinepi.2012.06.014","article-title":"Good test-retest reproducibility for an instrument to capture self-reported melanoma risk factors.","volume":"65","author":"Morze","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"doi220058r19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/azph.v45.5","article-title":"\u201cRepeatability of repeatability\u201d: the stability of self-reported melanoma risk factors in two independent samples.","volume":"45","author":"Mortimore","year":"2021","journal-title":"Aust N Z J Public Health"},{"issue":"10","key":"doi220058r20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/jnci\/djy023","article-title":"Risk stratification for melanoma: models derived and validated in a purpose-designed prospective cohort.","volume":"110","author":"Olsen","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"doi220058r21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/bjd.v183.2","article-title":"Does polygenic risk influence associations between sun exposure and melanoma? a prospective cohort analysis.","volume":"183","author":"Olsen","year":"2020","journal-title":"Br J Dermatol"},{"issue":"3","key":"doi220058r22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jid.2018.09.022","article-title":"Association between phenotypic characteristics and melanoma in a large prospective cohort study.","volume":"139","author":"Olsen","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"10","key":"doi220058r23","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.jclinepi.2006.01.009","article-title":"Using the outcome for imputation of missing predictor values was preferred.","volume":"59","author":"Moons","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"doi220058r24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","article-title":"Second-generation PLINK: rising to the challenge of larger and richer datasets.","volume":"4","author":"Chang","year":"2015","journal-title":"Gigascience"},{"key":"doi220058r25","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1080\/01621459.1989.10478873","article-title":"Regression analysis of multivariate incomplete failure time data by modelling marginal distributions.","volume":"84","author":"Wei","year":"1989","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"doi220058r26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/bjd.21649","article-title":"The effect of screening on melanoma incidence and biopsy rates.","volume":"187","author":"Whiteman","year":"2022","journal-title":"Br J Dermatol"},{"issue":"6","key":"doi220058r27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-4632.2007.02704.x","article-title":"Patient education and regular surveillance results in earlier diagnosis of second primary melanoma.","volume":"46","author":"Uliasz","year":"2007","journal-title":"Int J Dermatol"},{"issue":"8","key":"doi220058r28","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/1097-0142(20010415)91:8<1520::AID-CNCR1160>3.0.CO;2-6","article-title":"Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up.","volume":"91","author":"DiFronzo","year":"2001","journal-title":"Cancer"},{"issue":"3","key":"doi220058r29","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1245\/s10434-011-2058-8","article-title":"Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas.","volume":"19","author":"Murali","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"doi220058r30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2022.04.046","article-title":"Survival and tumor characteristics of patients presenting with single primary vs. second primary melanoma lesions.","author":"Sarver","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi220058r31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02316806","article-title":"Multiple primary melanomas: implications for screening and follow-up programs for melanoma.","volume":"4","author":"Brobeil","year":"1997","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"doi220058r32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.7326\/L18-0146","article-title":"Scrutiny-dependent cancer and self-fulfilling risk factors.","volume":"169","author":"Welch","year":"2018","journal-title":"Ann Intern Med"},{"issue":"5","key":"doi220058r33","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/jamadermatol.2022.0253","article-title":"Five-year outcomes of a melanoma screening initiative in a large health care system.","volume":"158","author":"Matsumoto","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"6","key":"doi220058r34","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1365-2133.2010.09961.x","article-title":"Multiple primary melanoma: the impact of atypical naevi and follow up.","volume":"163","author":"de Giorgi","year":"2010","journal-title":"Br J Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2798494\/jamadermatology_olsen_2022_oi_220058_1673370595.85988.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T11:04:12Z","timestamp":1674039852000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2798494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2022.4975","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,1]]}}}